Tags: canada.with.MS

Sort by: Date / Title / URL

1. BioMS shares drop 90 percent on disappointing MS result
   Shares of BioMS Medical Corp (MS.TO: Quote) plunged 90 percent on Tuesday after the company and Eli Lilly and Co (LLY.N: Quote) said their multiple sclerosis treatment failed to delay the progression of the disease in a late-stage trial.
   29-07-2009 to canada, clinical trial, ms, multiple sclerosis, research, spms by admin
2. Is your health too much information? - The Globe and Mail
   Information about employment rights in Canada (and a lively discussion)
   23-07-2009 to canada, ms, multiple sclerosis, work by admin
3. The Canadian Press: Drug body's advice against provinces paying for MS drugs seen as unfair
   An expert panel's advice that provinces and territories not cover the cost of two Multiple Sclerosis drugs creates a system of two-tiered care, MS advocates say.
   16-10-2007 to canada, drugs, government, sativex, tysabri by admin
4. globeandmail.com: New DNA vaccine holds hope for MS patients
   The vaccine incorporates the sequence of myelin basic protein (MBP), which is thought to be one of the targets of MS, and DNA is incorporated into the cells in the body, which then starts to make the protein.
   14-08-2007 to bht-3009, canada, genetics, ms, multiple sclerosis, research, treatment by admin
5. globeandmail.com: For a pot smoker in pain, no help is on the way
   A few weeks ago, though, Ms. Myrden's lustre was lessened after she was denied a summer student - one of five hired to give companionship to MS sufferers - by the Burlington chapter of the Multiple Sclerosis Society of Canada.
   12-08-2007 to canada, marijuana, ms, multiple sclerosis by admin
6. MS_ResearchTeleconference_P1.mp3 (audio)
   his year, Dr. Mark Freedman discusses the latest in MS research, progress in the bone marrow transplantation study and takes questions from callers.
   29-07-2007 to canada, ms, multiple sclerosis, research by admin
7. CEDAC Recommendation on Tysabri
   Decision of the CEDAC (Canada) on the use of Tysabri (natalizumab)
   29-07-2007 to canada, drugs, government, natalizumab, tysabri by admin
8. MS Society announces $2.4 M for stem cell research
   Two Ottawa researchers have been awarded a $2.4-million grant for their work in fighting multiple sclerosis, a chronic and often disabling disease of the brain and spinal cord.
   19-07-2007 to canada, multiple sclerosis, research, stemcell by admin
9. Man with MS given insanity diagnosis seeks compensation
   Anatole Otis, 67, has suffered from multiple sclerosis for more than a decade, but was diagnosed as demented when he first sought medical attention.
   04-07-2007 to canada, diagnosis, government, multiple sclerosis by admin
10. Colgate's Mike Campaner Goes Public with Diagnosis of Multiple Sclerosis
    Senior defenseman Mike Campaner (Thunder Bay, Ont.) of the Colgate University men's hockey team made public today that he suffers from multiple sclerosis, an auto-immune disease that affects the central nervous system. Campaner was diagnosed with MS in D
    30-06-2007 to canada, exercise, life, multiple sclerosis, people, us by admin
11. globeandmail.com: RCMP looking into death of Nova Scotia woman
    he husband of a Nova Scotia woman who died at an assisted-suicide clinic in Switzerland this month said yesterday he doesn't fear a police investigation into the matter and doesn't expect charges to be laid against him.
    28-06-2007 to canada, government, multiple sclerosis, people by admin
12. Neurological conditions cost Canada nearly $9B a year: report
    The neurologists called for new priorities in health care, saying billions could be saved through earlier diagnoses, stroke prevention programs and Alzheimer's research.
    23-06-2007 to canada, government, multiple sclerosis, news by admin
13. Easier Access to Multiple Sclerosis Treatments Will Reduce Overall Healthcare Costs: MS Society
    The cost of MS to the Canadian economy is estimated to be more than $1 billion per year.
    25-05-2007 to canada, ms, multiple sclerosis, organization, study by admin
14. BioMS Medical Announces Lead Investigator In United States Phase III Multiple Sclerosis Trial
    BioMS Medical Corp (TSX: MS), a leading developer in the treatment of multiple sclerosis (MS), is pleased to announce Dr. Clyde E. Markowitz as the lead investigator in the United States for the Company’s pivotal phase III clinical trial of its lead dru
    28-04-2007 to canada, drug company, drugs, mbp8298, multiple sclerosis, spms by admin
15. Wandering Wonder
    I've become this (self-proclaimed) posterchild for MS. I have been open about it. I've been okay with it.
    01-04-2007 to blog, canada, multiple sclerosis, people by admin

First / Previous / Next / Last / Page 1 of 5